Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
about
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentagesChemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerChemotherapy and radiotherapy for inoperable advanced pancreatic cancerChemotherapy and radiotherapy for inoperable advanced pancreatic cancerRandomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferationAddition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trialsLow expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancerThe role of radiotherapy in multimodal treatment of pancreatic carcinomaPancreatic cancer-improved care achievableTrends in the treatment of resectable pancreatic adenocarcinoma.Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Adjuvant therapy in pancreatic cancer.The anatomic location of pancreatic cancer is a prognostic factor for survival.Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Biology and management of pancreatic cancer.A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activationPancreas cancer survival in the gemcitabine eraAdjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.Chemoradiation in pancreatic adenocarcinoma: a literature review.Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma.Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth.Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma.Pancreatic Cancer: Current Options for Diagnosis, Staging and Therapeutic ManagementSuccessful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of lifeMeta-analyses of treatment standards for pancreatic cancer.Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection.Medical treatment of pancreatic cancer.Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancerPancreatic cancer: why is it so hard to treat?Survival from cancer of the pancreas in England and Wales up to 2001The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis.
P2860
Q21092323-14E0E369-324B-48A4-90AE-A47894A1DE25Q24194621-72678E66-B875-4A85-BF1C-05967088A8F5Q24240739-D248A322-9290-40DF-963B-9A3E832D68A3Q24245085-C347DA4C-1AD4-4DC1-B3A3-7244086194AFQ24816432-15482909-CA54-4E92-B67C-0960338DCE9CQ28293407-E775199E-96A8-4349-9F5E-4493A58056B6Q30987695-B7FC20F9-BFD9-47C6-88BA-6BD441F120E2Q33398018-E4A16EA8-BD0B-4377-9BB6-C55ABC94DCFFQ33943803-F9A384CF-7418-4306-8C07-577E51EF3C5DQ34025910-E604C510-FD8A-42D0-B225-9C3D117A9B24Q34036659-374C3A41-E213-4DA9-9528-E22808D15458Q34062486-1C32F365-2F2D-4FB8-8B5C-ED54A83422FCQ34121237-635E4E08-459D-4339-8B49-106B62B85D33Q34405072-E9485917-4CED-4446-A4A9-63D5094AA527Q34599751-25823F35-2981-44ED-AF00-CC9C30FFA690Q34635042-7EA6F9CE-B1F1-4BCC-87FC-7AF488893D68Q34649019-3252254A-FA2B-46BF-98EE-5D24E9462D68Q34904065-F3B87A2F-9624-4C84-B428-CA9F9DD84A65Q35181008-0008C4CD-66BB-471F-8ACF-344070D4FD6DQ35504794-68708AA2-7143-4CEA-9E28-252A255C8482Q35583949-02C9559A-CD0E-44D0-8F61-376D59BBDECEQ35627199-54672386-EE6D-42C6-8BB1-F0F157857D72Q35769170-3844EC77-B74C-4964-9F56-F5BA4B0F0EBEQ35785646-384921FD-6672-4C68-B237-AF516808BF9AQ35848380-447B9B45-6AE9-4F0C-8692-90E6556BFD16Q36000813-28579834-4A55-4F92-92BD-8309A454822AQ36029954-3F1E9E85-4EF6-4438-9FB7-5D9873BFF338Q36113317-B0128390-78F4-4175-91E8-7A861EEEF034Q36143603-BD2C8950-2055-4A80-A3D5-1DD9412B7D59Q36253159-E1478369-8526-4CE6-B066-B4A04B58E1E9Q36281575-8EE9B6C6-F59F-4C23-9ABC-9BD5772EFF10Q36544488-D2E1A9CC-EE40-4C4E-BC11-D5DD3DB7789BQ36640493-E7E1CCFC-A7CB-480B-BC0C-D1E5EAE0B5A6Q36666606-5DF55260-DE9B-42C5-863E-D5578498CF65Q36747432-0577A213-A029-40E9-B5DC-74F8C7D83FA7Q36788494-1C8AD276-48D6-4ACE-B932-82CF1FAB7086Q36859193-5CEA64B1-1A36-45B2-8210-26BA843248E5Q36886497-8CD14191-D18A-4699-8963-4FE11E2B2BBDQ36917717-358CC2F0-FCC1-46BF-9A0B-723AA47EF9DCQ37054817-BE665B98-2816-4028-8F7E-F4A9A053973C
P2860
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@ast
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@en
type
label
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@ast
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@en
prefLabel
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@ast
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@en
P2093
P2860
P356
P1476
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
@en
P2093
C Dervenis
D D Stocken
J H G Klinkenbijl
J P Neoptolemos
K E Bakkevold
Pancreatic Cancer Meta-analysis Group
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602513
P407
P577
2005-04-01T00:00:00Z
P5875
P6179
1015676534